Skip to main navigation Skip to search Skip to main content

Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.

Translated title of the contribution: Targeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
  • M.D. Wissing
  • , J. Mendonca
  • , M.S.Q. Kortenhorst
  • , N.S. Kaelber
  • , M. Gonzales
  • , E. Kim
  • , H. Hammers
  • , P.J. van Diest
  • , M.A. Carducci
  • , S.K. Kachhap

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contributionTargeting prostate cancer cell lines with polo-like kinase 1 inhibitors as a single agent and in combination with histone deacetylase inhibitors.
Original languageUndefined/Unknown
Pages (from-to)4279-4293
Number of pages15
JournalFASEB Journal
Volume27
Issue number10
Publication statusPublished - 2013

Cite this